Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization

British Journal of Haematology

Volumn 93, Issue 1, 1996, Pages 163-165

  Lowsky, Robert ^b   Fyles, Gillian ^b   Minden, Mark ^b   Lipton, Jeefrey ^b   Meharchand, Jacinta ^b   Tejpar, Ismet ^b   Zipursky, Alvin ^a   Messner, Hans ^b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

AML; bone marrow transplantation; CML; donor cell derived secondary leukaemia; FISH

Indexed keywords

BCG VACCINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DONOR; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

ADULT; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 7; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029936733     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.454991.x     Document Type: Article

References (10)

1. Anastasi, J., Thangavelu, M., Vardiman, J.W., Hooberman, A.L., Bian, M.L., Larson, R.A. & Lebeau, M. (1991) Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of relapse after allogeneic bone marrow transplantation. Blood, 77, 1087-1091.
2. Cransac, M., Boiron, J.M., Merel, P., Makhoul, P.C., Marit, G., Bernard, P., Ferrer, J. & Reffers, J. (1993) Burkitt-type acute lymphoblastic leukemia in donor cells after allogeneic bone marrow transplantation for acute nonlymphoblastic leukemia. Transplantation, 56, 120-123.
3. Fyles, G.M., Messner, H.A., Lockwood, G., Lipton, J., Minden, M., Meharchand, J., Curtis, J. & Sutcliffe, S. (1991) Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate. Bone Marrow Transplantation, 8, 453-463.
4. McCann, S.R., Lawler, M. & Bacigalupo, A. (1993) Recurrence of philedelphia chromosome positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia. Leukemia and Lymphoma, 10, 419-425.
5. Minden, M., Messner, H. & Belch, A. (1985) Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism. Journal of Clinical Investigation, 75, 91-93.
6. Naoe, T., Kiyoi, H., Yamanaka, K., Naito, K. & Kazumasa, Y. (1989) A case of cALL relapse after allogeneic BMT: recurrence of recipient cell origin, initially determined as being that of donor cell origin by sex chromosome analysis. British Journal of Haematology, 73, 420-422.
7. Smith, J, Heerema, N.A. & Provisor, A.J. (1985) Leukaemic transformation of engrafted bone marrow cells. British Journal of Haematology, 60, 415-422.
8. Stein, J., Zimmerman, P.A., Kochera, M., Strandjord, S., Golden, W., Simon, H., Warkentin, P., Blazar, B.R., Coccia, P. & Lang-Unnasch, N. (1989) Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses. Blood, 73, 2033-2040.
9. Trask, B. & Pinkel, D. (1990) Fluorescence in situ hybridization with DNA probes. Methods in Cell Biology, 33, 383-390.
10. Witherspoon, R.P., Schubach, W., Neiman, P., Martin, P. & Thomas, E.D. (1985) Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood, 65, 1172-1174.